Form 4: Lexaria Bioscience Corp. Executive Vanessa Carle Reports Sale of Common Shares
SEC Form 4
Vanessa Carle, Secretary of Lexaria Bioscience Corp., reports the sale of 2,567 common shares on July 31, 2024.
Summary
- On July 31, 2024, Vanessa Carle, the Secretary of Lexaria Bioscience Corp., sold 2,567 common shares.
- The shares were sold at a price of $4 per share.
- Following the transaction, Carle directly owns 0 common shares.
- Carle also holds warrants for 67 common shares and various stock options with different exercise prices and expiration dates.
Sentiment
Score: 5
Explanation: The document is a standard SEC Form 4 filing, reporting a sale of shares by an officer. It doesn't inherently convey positive or negative sentiment, but rather provides factual information about the transaction.
Key Dates
| Date | Description |
|---|---|
| 11/13/2019 | Date of Warrants |
| 04/26/2021 | Date of Stock Options |
| 06/08/2021 | Date of Stock Options |
| 09/01/2021 | Date of Stock Options |
| 08/29/2022 | Date of Stock Options |
| 05/09/2023 | Shareholder approval received for repricing stock options |
| 10/26/2023 | Date of Stock Options |
| 04/26/2024 | Date of Stock Options |
| 07/31/2024 | Date of transaction: Sale of 2,567 common shares |
| 08/01/2024 | Date of signature for the Form 4 filing |
| 11/13/2024 | Expiration Date of Warrants |
| 04/26/2026 | Expiration Date of Stock Options |
| 06/08/2026 | Expiration Date of Stock Options |
| 09/01/2026 | Expiration Date of Stock Options |
| 08/29/2027 | Expiration Date of Stock Options |
| 10/26/2028 | Expiration Date of Stock Options |
| 04/26/2029 | Expiration Date of Stock Options |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.